UCB’s Cimzia BLA Could Provide First Subcutaneous Injection For Crohn’s
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
UCB is touting the "greater convenience" of its Cimzia subcutaneous injection for Crohn's disease compared to Johnson & Johnson's intravenous injection Remicade